Germany – Pharmaceutical products – Arzneimittelverträge mit Beitrittsoption
Description
This notice does not concern the award of a public contract within the meaning of the Public Procurement Directive (2014/24/EU) or of public procurement law. In the interest of providing as wide an information as possible to interested pharmaceutical companies, this notice is published in the Supplement to the Official Journal of the European Union. The use of the procedure designation "Open Procedure" (Section IV.1.1) in the present notice text is due to the requirements of the notice form. Neither the use of this designation nor the use of the medium "TED" implies any submission to procurement regulations, the application of which is not mandatory by law or by procurement regulations. This is a framework agreement with an option to join, relating to various active substances.
CPV codes
Documents & submission
Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.
Related tenders
Germany – CT scanners – Beschaffung von 2 CT und 2 Angioanlagen in 2 Kombinationslosen
Klinikum der Stadt Ludwigshafen am Rhein gGmbHGermanyCT scannersDigital angiography devicesRepair and maintenance services of medical and precision equipmentNo deadline givenPublished on Oct 20, 2026
Germany – Medical equipments – Rahmenvertrag über die Lieferung von corPatch Stimulationselektroden und EKG-Papier für C3 Defibrillatoren im Rettungsdienst der Stadt Essen
Stadt Essen, Zentrales VergabemanagementGermanyMedical equipmentsMedical consumablesMiscellaneous medical devices and productsDeadline in 12 daysPublished on Oct 20, 2026
Germany – Medical equipments, pharmaceuticals and personal care products – 1/DLII6/VM138 - RV Medizinprodukte, divers
Bundesamt für Infrastruktur, Umweltschutz und Dienstleistungen der BundeswehrGermanyMedical equipments, pharmaceuticals and personal care productsDeadline in 13 daysPublished on Oct 20, 2026
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Certolizumab pegol (ATC-Code nach WHO: L04AB05)
AOK PLUS - Die Gesundheitskasse für Sachsen und ThüringenGermanyPharmaceutical productsDeadline in 71 daysPublished on Oct 20, 2026